Evidence map›Paper›PMID 27929747›Full record

ArticlemAbs

Localized conformational interrogation of antibody and antibody-drug conjugates by site-specific carboxyl group footprinting.

Lucy Yan Pan, Oscar Salas-Solano, John F Valliere-Douglass

Abstract read
In one paragraph

Article in mAbs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lucy Yan Pana Seattle Genetics, Inc. , Bothell , WA , USA.
Oscar Salas-Solanoa Seattle Genetics, Inc. , Bothell , WA , USA.
John F Valliere-Douglassa Seattle Genetics, Inc. , Bothell , WA , USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Establishing and maintaining conformational integrity of monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) during development and manufacturing is critical for ensuring their clinical efficacy. As presented here, we applied site-specific carboxyl group footprinting (CGF) for localized conformational interrogation of mAbs. The approach relies on covalent labeling that introduces glycine ethyl ester tags onto solvent-accessible side chains of protein carboxylates. Peptide mapping is used to monitor the labeling kinetics of carboxyl residues and the labeling kinetics reflects the conformation or solvent-accessibility of side chains. Our results for two case studies are shown here. The first study was aimed at defining the conformational changes of mAbs induced by deglycosylation. We found that two residues in C

Indexed as

AnimalsAntibodies, MonoclonalDeuterium Exchange MeasurementHumansImmunoconjugatesKineticsMass SpectrometryProtein EngineeringAntibodies, MonoclonalImmunoconjugatesAntibody-drug conjugatecarboxyl group footprintingcovalent labelinghydrogen-deuterium exchangemass spectrometrymonoclonal antibodyProtein conformationrate constantside chainssolvent accessibility

Identifiers

PMID27929747
PMCPMC5297533

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.